Analysis of the genetic variants associated with circulating levels of sgp130. Results from the IMPROVE study

The genes regulating circulating levels of soluble gp130 (sgp130), the antagonist of the inflammatory response in atherosclerosis driven by interleukin 6, are largely unknown. Aims of the present study were to identify genetic loci associated with circulating sgp130 and to explore the potential asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonomi, Alice, Veglia, Fabrizio, Baldassarre, Damiano, Strawbridge, Rona J., Golabkesh, Zahra, Sennblad, Bengt, Leander, Karin, Smit, Andries J., Giral, Philippe, Humphries, Steve E., Tremoli, Elena, Hamsten, Anders, de Faire, Ulf, Gigante, Bruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182533/
https://www.ncbi.nlm.nih.gov/pubmed/31932740
http://dx.doi.org/10.1038/s41435-019-0090-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7182533/
https://www.ncbi.nlm.nih.gov/pubmed/31932740
http://dx.doi.org/10.1038/s41435-019-0090-z

Ejemplares similares